Eire batter Rebecca Stokell has admitted to an anti-doping rule violation after a sample collected through the 2026 T20 World Cup returned an hostile finding for a specified substance.
The Worldwide Cricket Council (ICC) informed her of the alleged breach, and she or he accepted the violation. The matter was linked to her use of prescription medication. Cricket Eire described it as an inadvertent breach of reporting requirements and mentioned the substance was non-performance enhancing. Stokell has accepted a voluntary suspension while the disciplinary course of continues.
The sample was collected during an in-competition take a look at on June 23, 2026, when Stokell played for Eire against Sri Lanka in Bristol. Eire lost that T20 World Cup match by nine wickets. The ICC later notified her that the sample had returned an hostile finding for a Specified Substance. After receiving the notification, Stokell admitted the violation and agreed to a voluntary suspension.
The suspension took impact on October 23, 2026, pending the outcome of the disciplinary course of. The notification adopted the sample collected through the tournament, and the suspension remains in place while the disciplinary course of determines the outcome of the case. The ICC introduced the matter in a media launch on November 2, 2026, and mentioned it will not comment further until the case is resolved.
The ICC confirmed the small print in its statement, saying: “Following the receipt of the notification, Stokell has admitted the violation, which arose from her use of prescription medication, and accepted a voluntary suspension efficient 23 October 2026 pending the outcome of the disciplinary course of.” The council mentioned the sample had returned an hostile finding for a Specified Substance. It also confirmed that Stokell had admitted the violation and accepted the suspension. The ICC added that it will make no further comment until the matter had been lastly resolved.
Cricket Eire described the incident as an “inadvertent breach of the reporting requirements” and mentioned the substance was non-performance enhancing. Stokell accepted responsibility for her mistake and explained that she had entered the suspension voluntarily.
She mentioned: “I absolutely accept my mistake and have voluntarily entered into a interval of suspension ahead of the findings being returned.” She added: “Whereas this was not efficiency related in any way, I understand that I’m chargeable for following the anti-doping guidelines and I hope that I could be again playing for Eire as quickly as attainable.”
Stokell, 26, made her worldwide debut in 2017 and has since played 29 ODIs and 80 T20Is for Eire. She featured in all 5 of Eire’s matches on the 2026 T20 World Cup, scoring 40 runs at a mean of 10. Her highest score was 16 not out. Eire recorded one win from 5 video games, beating West Indies by six wickets in their ultimate league match. Earlier, that they had lost to Sri Lanka by nine wickets in Bristol, the match during which Stokell provided the sample linked to the case.
Stokell’s most up-to-date assignment earlier than the announcement was Eire’s ODI series in England in September 2026, which the hosts won 3-0. Across her ODI career, she has scored 468 runs, including three half-centuries. In T20Is, she has made 908 runs and recorded one half-century. Her worldwide career started in 2017 and includes 29 ODI appearances and 80 T20I appearances. The case is now awaiting the outcome of the ICC’s disciplinary course of.
Stokell has admitted the violation related to prescription medication and has been below voluntary suspension since October 23, 2026. Cricket Eire called the reporting breach inadvertent and mentioned the substance was not efficiency enhancing. The ICC won’t comment further until the matter is resolved.
On a mission to advertise women’s cricket around the globe! Observe our story:
Source: femalecricket.com
